APPLICATION
ANDA204435
TYPE
ANDA
ORIGINAL APPROVAL
2016-06-10
LATEST ACTION
2025-03-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
NEOMYCIN SULFATEDiscontinued
NEOMYCIN SULFATE 500MG · TABLET · ORAL
Approval history
2025-03-27Labeling · Supplement 7 · standardAP
2023-02-10Labeling · Supplement 5 · standardAP
2016-06-10UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.